Alpha interferon as an immunomodulator in the treatment of patients with tumors.
Department of Medicine, Hospital Universitario Principe de Asturias, Hospital Universitario General de Guadalajara, Universidad de Alcala de Henares, Spain.
M
M
Alvarez-Mon
O J
OJ
Salmerón
L
L
Manzano
M
M
Rodríguez-Zapata
E
E
Reyes
L M
LM
Vaquer
J
J
Carballido
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents / Q000145:classification / Q000378:metabolism / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D016898:Interferon-alpha / Q000145:classification / Q000378:metabolism / Q000627:therapeutic use*; D007694:Killer Cells, Natural / Q000276:immunology; D007963:Leukocytes, Mononuclear / Q000276:immunology; D009369:Neoplasms / Q000628:therapy*; D010051:Ovarian Neoplasms / Q000628:therapy
D000276:Adjuvants, Immunologic; D000970:Antineoplastic Agents; D016898:Interferon-alpha